06:50 AM EDT, 10/28/2025 (MT Newswires) -- GeneDx Holdings ( WGS ) reported Q3 adjusted earnings Tuesday of $0.49 per diluted share, up from $0.07 a year earlier.

Analysts polled by FactSet expected $0.42.

Revenue for the quarter ended Sept. 30 was $116.7 million, compared with $76.9 million a year earlier.

Analysts surveyed by FactSet expected $104.6 million.

For 2025, the company raised its revenue guidance range to now be between $425 million and $428 million, from its previous guidance range of between $400 million and $415 million. Analysts polled by FactSet expect $411.7 million.

Shares of the company were up over 12% in recent Tuesday premarket activity.

Price: 147.00, Change: +16.34, Percent Change: +12.51